Btg Share Discussion Threads

[fhmktg] 27/1/2017 17:28

Well,that was a pleasant end to the week!

[fhmktg] 26/1/2017 16:27

Sadly it's just traders consistently trading down ,but no serious or institutional investors taking advantage of the substantial drop in share price over the last period.With no sign of a dividend in sight and the P/E ratio so high, they have no reason to invest.Heaven help us if Mr W decides to get out!The next 12 months are critical for BTG and its growth success story.If the increase in earnings continues at the sprightly clip of the last few years and EVERY sector of the company maintains its growth then sentiment will return and I believe an announcement of the beginning of sustained dividend payments could be in the next two years.Any shocks on the downside and it could be curtains for Louise and her team!

[knowbodyyouno] 26/1/2017 16:16

Brokers' still calling it a buy with lofty price targets still being released. There's sone concerted selling here no doubt.

[knowbodyyouno] 26/1/2017 16:15

Everyday I log on with renewed hope that the downward spiral will arrest itself. At first I put it down to Trump and his conference promise re drug prices. However, this isn't across the market. Perhaps something more sinister is going on. Whatever the case, everyday it continues. Will have to sell out soon with a punishing loss - £7,000 down now in just a few days and with no end in sight. More fool me for investing here.

[a1ord53] 26/1/2017 14:34

Anybody knows where is Biotech Guru Mr Woodford ?
All his creations are being falling aparts . And he is not buying anymore.Very bad sign imo.
Where is management ? Are they( insiders )selling now ? And we will be like always informed after they sold .Why analysts without any published news cutting their target prices . What they know what we dont know ?There were no news since results in November .

[steeplejack] 25/1/2017 20:33

It certainly looks like broker forecasts are being massaged down.Couple of years ago,I seem to remember price forecasts of over £10 albeit that was the 'run of the mill' simplistic broker extrapolations.Reading through other bulletin boards ,as I'm sure others have done,the private investor mood can best be described as twitchy.Looking back perhaps the market was overly sanguine about Varithena.In fact,it would appear Varithena was always subject to a fair bit of scepticism from certain quarters.As always,I find myself doing more due diligence to explain why I'm holding a loss making share than the reverse and frankly,I was clearly a bit slipshod here when I tucked BTG in with a portfolio of other pharmaceuticals shares....especially given the rating.I'm not fussed about the absence of dividend but I do think the management should accept that things are well short of best expectations.There could be a marked deceleration in growth in couple of years out,could there not?Hey ho.

[a1ord53] 25/1/2017 16:09

No Trump , no brexit responsible for btg fall.
Louis and Rolf plus inactive major shareholders responsible for incompetence of management.
Management failed - Varithena, Forex hedges, Biocompatible garbage and penalties 38 million and sales of shares by Louis and Rolf many times before bad rns's.
They having huge salories, options and no responsibilities !!!
Peal hunt issued hold and target price 6,30 £
So we are going down with all brokers new share price targets. They all cut their targets prices and I am afraid that share price going only one direction - down. Short sellers will continue to kill sp, cause they can and major shsteholders dont care , because they invested other people's money :(
Where is legendary Woodford ? Btg bust and his other child Vectura is bust too.

25 Jan 17 Numis Buy 539.00 900.00 900.00 Reiterates
25 Jan 17 Peel Hunt Hold 539.00 - 630.00 Initiates/Starts
24 Jan 17 Jefferies International Buy 539.00 860.00 775.00 Reiterates
17 Jan 17 JP Morgan Cazenove Neutral 539.00 - - Reiterates
26.01.2017 Deutsche Bank today reaffirms its buy investment rating on BTG PLC (LON:BTG) and cut its price target to 775p (from 800p). Story provided by StockMarketWire.com

[steeplejack] 25/1/2017 15:12

It is specific to BTG despite the uncertain backcloth provided by Mr Trump.A more stringent drug pricing environment has been likely for some years regardless of whether it's a Republican or Democrat administration.If you look at the biotech investment trusts,you will see that they are well off the lows they hit some months back.Indeed they have enjoyed a steady recovery albeit they're marking time at the moment.As far as large companies like Shire are concerned ,they've given back the post Brexit rally admittedly,being well off their highs hit in the Autumn but remain markedly higher than prices seen in the Spring of 2016.

BTG is less than 10% off hitting a three year low.Maybe uncertainty is exacerbating the price fall in BTG but it is most certainly not the primary explanation.

[weatherman] 25/1/2017 10:43

Yes, your right - its now 2017 so last year means 2015.

[cumnor] 25/1/2017 10:35

All small pharma being crucified at present largely on back of Trump warnings, though they are less relevant to small companies but at some stage will be worth investing in as demand for products going only one way and investors (if he wants innovation) will pull back from US and UK soon if he keeps ramping up the rhetoric. Pharma jobs more sustainable long term than steel jobs he will learn. imo

[a1ord53] 25/1/2017 10:15

weatherman , this was in october 2015.
since then no improvement showing.
in october JPM lowered target price frim 11£ to 10 £ and now jpm neutral with target price 7 £

[fhmktg] 25/1/2017 09:58

Pre-close statement in April and the results in May will be crucial.Maintaining the 30% year on Year growth in Earnings with positive forward indications are critical....Varithena confirming growth and expectations for permanent codes will be the icing.Getting that P/E ratio down to mid 20s is important and the precursor to dividend payments which must surely come in the next 1/2 years.

[gregmorg] 24/1/2017 15:06

Must admit Steeplejack it does have many of the signs of testing the institutional shareholder base for some stock so I guess there could be a deal on its way. That thought doesn't please me at all at these levels and we could easily be wrong but something is driving this thing ! Given the momentum the answer cannot be far away either

[steeplejack] 24/1/2017 14:58

I start with the proviso that you should never hold for a takeover (the last resort of the unlucky punter)but in the case of BTG it's quite possible.Takeovers of small to medium pharmaceuticals are perennial.The industry seems to have a proclivity for looking after its own,simply because the major assets go up and down in the lift I guess and can be relatively easily integrated.I go along with JPM in suspecting that BTG is mulling a further acquisition.Despite the company's rather self congratulatory comments and declarations that it is all about the drive for growth (dividends be damned)the company can't believe that it's anywhere near exceeding expectations.Actually,I sense a rather testy management manner,reiterating to the sceptic that's it all about the building of value for the long term."The long term",isn't that a bit like an irritated shareholder reassuring himself that ultimately the company will be taken over !Yet again the stock has fallen to bottom of its trading range and one can but hope it bounces.This company is a disappointingly boring hold.

[a1ord53] 24/1/2017 14:32

Fhmktg, I dont believe Louis . She is happy with her salory and never tried to buy on dips and hold big position in btg and the same her collegue Rolf.
If She believes in her company and by her built model, She had to buy and accumulate shares of btg.
I dont understand why major shareholders not fired her yet.
She ruined Varithena imo.Her team is incompitent.She did bad forex hedge. Millions lost. And She not yet fired !
Jefferies reissued buy recommendation but cut target price to 7,75 £ from 8,80 £. Market takes this recommendation as sell signal.
No second Shire at all :(

[fhmktg] 24/1/2017 14:08

Protherics were my entry point and I have been fascinated and well rewarded by the work which Dame Louise has put in building the group.But I don't believe that the PR effort has worked to maintain the positive image which BTG deserve as a British success story. This company deserves better than being a pawn of day traders.If Mr Woodford decides he can't wait much longer, I far a US hedge fund could move in as an activist to force change and then sell out.Another British jewel sold off and Louise's dream of being the next Shire come to nought.

[gregsc] 24/1/2017 13:12

fhmktg, I agree with you entirely.
I have had these shares for 10 years now, and in BTG's case
'no news is bad news'.

[salpara111] 24/1/2017 12:26

Sadly it looks like it is going back to test the 500p area.
I have had them on my watch list for a while but not taken a stake yet.
If it does head for the 510 region I will most likely get on board.

[a1ord53] 24/1/2017 12:24

Varithena is fully discounted in share price But Echosphere and other purchases not valued in share price
Management doesnt hold significant position in btg and obviously dont care about share price Why ? Cause they selling their options - shares right aweay.
Short sellers in control.
Management brought again shareholders to misery. Major shareholders not buying at all and loaning their shares to short sellers ( Aviva ).
Trading is extremely illiquid and for majors no way to escape with their holdings totaled 65-70%.
Take over ? Would be miracle. Lets hope.

[fhmktg] 24/1/2017 08:25

Ffs...get some pr action going!Sing the praises of what the Company is doing to help health outcomes for patients instead of blindly allowing traders to make money on Mr T's latest ranting!

[steeplejack] 24/1/2017 08:20

More reassuring than the share price performance which suggests that BTG have lost their investor "sparkle".

[fhmktg] 23/1/2017 15:41

A number of US vein treatment centres are now promoting Varithena through their websites...just Google Varithena 2017 and scan down the links.San Diego and Tennessee amongst those listed.Reassuring!

[fhmktg] 19/1/2017 16:02

President GH Bush just treated with a 'procedure' to help his breathing. Hope it was PneumRx.

[steeplejack] 12/1/2017 12:05

Yes of course it was Clinton who is anti pharma and has been for a quarter of a century.Pointing out that the drug companies spend far too much entertaining customers and charge excessively high prices.Trump,however,also indicated during the electioneering that he was happy to entertain a tougher pricing regime for pharma companies.One's got to assess whether the tougher climate isn't potentially discounted in a sector that has lagged the broader market.